RESEARCH-USE BIOSIMILAR ANTIBODY
Conatumumab
Monoclonal antibody · IgG1
Conatumumab (AMG 655) is a human monoclonal agonist antibody against human death receptor 5 (DR5, TRAILR2) (Kd: 1 nM for the long form of DR5, 0.8 nM for the short form of DR5). Conatumumab induces apoptosis via caspase activation. Conatumumab can be used in the research of cancers. .
TARGETTNFRSF10B
YMonoclonal antibody
CATALOGSC-BS-655
CATALOG NUMBERSC-BS-655
MOLECULAR WEIGHTApprox. 145.44 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Conatumumab (AMG 655) is a human monoclonal agonist antibody against human death receptor 5 (DR5, TRAILR2) (Kd: 1 nM for the long form of DR5, 0.8 nM for the short form of DR5). Conatumumab induces apoptosis via caspase activation. Conatumumab can be used in the research of cancers. .
Conatumumab is a recombinant research-use antibody directed against TNFRSF10B.